16-83899588-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_012213.3(MLYCD):​c.444C>T​(p.Asp148Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0126 in 1,589,408 control chromosomes in the GnomAD database, including 435 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.033 ( 198 hom., cov: 33)
Exomes 𝑓: 0.010 ( 237 hom. )

Consequence

MLYCD
NM_012213.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.805

Publications

2 publications found
Variant links:
Genes affected
MLYCD (HGNC:7150): (malonyl-CoA decarboxylase) The product of this gene catalyzes the breakdown of malonyl-CoA to acetyl-CoA and carbon dioxide. Malonyl-CoA is an intermediate in fatty acid biosynthesis, and also inhibits the transport of fatty acyl CoAs into mitochondria. Consequently, the encoded protein acts to increase the rate of fatty acid oxidation. It is found in mitochondria, peroxisomes, and the cytoplasm. Mutations in this gene result in malonyl-CoA decarboyxlase deficiency. [provided by RefSeq, Jul 2008]
MLYCD Gene-Disease associations (from GenCC):
  • malonic aciduria
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Orphanet, PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.24).
BP6
Variant 16-83899588-C-T is Benign according to our data. Variant chr16-83899588-C-T is described in ClinVar as Benign. ClinVar VariationId is 95500.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.805 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.093 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_012213.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MLYCD
NM_012213.3
MANE Select
c.444C>Tp.Asp148Asp
synonymous
Exon 1 of 5NP_036345.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MLYCD
ENST00000262430.6
TSL:1 MANE Select
c.444C>Tp.Asp148Asp
synonymous
Exon 1 of 5ENSP00000262430.4
ENSG00000288849
ENST00000689373.1
n.1202-7399C>T
intron
N/A
ENSG00000288849
ENST00000692462.1
n.1170-7399C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0331
AC:
5043
AN:
152198
Hom.:
196
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0951
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0147
Gnomad ASJ
AF:
0.0242
Gnomad EAS
AF:
0.00154
Gnomad SAS
AF:
0.00269
Gnomad FIN
AF:
0.00970
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00913
Gnomad OTH
AF:
0.0215
GnomAD2 exomes
AF:
0.0132
AC:
2678
AN:
202962
AF XY:
0.0121
show subpopulations
Gnomad AFR exome
AF:
0.0979
Gnomad AMR exome
AF:
0.00666
Gnomad ASJ exome
AF:
0.0196
Gnomad EAS exome
AF:
0.000124
Gnomad FIN exome
AF:
0.0141
Gnomad NFE exome
AF:
0.0105
Gnomad OTH exome
AF:
0.0120
GnomAD4 exome
AF:
0.0104
AC:
14934
AN:
1437094
Hom.:
237
Cov.:
30
AF XY:
0.0100
AC XY:
7161
AN XY:
714780
show subpopulations
African (AFR)
AF:
0.101
AC:
3323
AN:
32844
American (AMR)
AF:
0.00866
AC:
380
AN:
43872
Ashkenazi Jewish (ASJ)
AF:
0.0206
AC:
533
AN:
25814
East Asian (EAS)
AF:
0.000205
AC:
8
AN:
39020
South Asian (SAS)
AF:
0.00193
AC:
164
AN:
85022
European-Finnish (FIN)
AF:
0.0125
AC:
465
AN:
37186
Middle Eastern (MID)
AF:
0.00917
AC:
51
AN:
5560
European-Non Finnish (NFE)
AF:
0.00826
AC:
9148
AN:
1108034
Other (OTH)
AF:
0.0144
AC:
862
AN:
59742
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
926
1852
2777
3703
4629
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
376
752
1128
1504
1880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0333
AC:
5070
AN:
152314
Hom.:
198
Cov.:
33
AF XY:
0.0319
AC XY:
2373
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.0955
AC:
3970
AN:
41572
American (AMR)
AF:
0.0146
AC:
224
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.0242
AC:
84
AN:
3470
East Asian (EAS)
AF:
0.00154
AC:
8
AN:
5184
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4832
European-Finnish (FIN)
AF:
0.00970
AC:
103
AN:
10624
Middle Eastern (MID)
AF:
0.0137
AC:
4
AN:
292
European-Non Finnish (NFE)
AF:
0.00913
AC:
621
AN:
68006
Other (OTH)
AF:
0.0213
AC:
45
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
240
480
719
959
1199
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0202
Hom.:
25
Bravo
AF:
0.0370
Asia WGS
AF:
0.00866
AC:
32
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Deficiency of malonyl-CoA decarboxylase Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

not specified Benign:2
Dec 31, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Nov 28, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.24
CADD
Benign
12
DANN
Benign
0.96
PhyloP100
0.81
PromoterAI
0.095
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs62640904; hg19: chr16-83933193; API